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Mutations in the B1 subunit of the multisubunit vacuolar
ATPase cause autosomal-recessive distal renal tubular
acidosis and sensorineural deafness. Here, we report a novel
frameshift mutation that truncates the C-terminus of the
human B1 subunit. This mutant protein failed to assemble
with other subunits in the cytosol to form the complex that
can be targeted to vesicular structures in mammalian cells.
Loss of proton pump activity was demonstrated in a
functional complementation assay in B-subunit null yeast.
The mutation caused loss of a discreet C-terminal region
critical for subunit interaction not related to the C-terminal
PDZ motif. Co-expression studies failed to demonstrate
dominant negative effects of this truncated mutant over
wild-type B1. Analysis of 12 reported B1 subunit missense
mutations showed one polymorphic allele had intact pump
function, two point mutants had intact assembly but
defective proton pumping, and the remaining nine had
disrupted assembly with no pump function. One presumed
polymorphic allele was actually an inactivating mutation. Our
study shows that multiple mechanisms of pump dysfunction
result from B1 subunit mutations with a common outcome
being defective assembly. Polymorphisms of the B1 subunit
in the general population may affect renal acidification and
urinary chemistry.
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The V-ATPase belongs to the ubiquitous families of
ATP-driven Hþ -translocating ion pumps, which also include
F- and P-ATPase families. In mammals, F-ATPases mediate
mitochondrial ATP synthesis, whereas V-ATPases serve
multiple cellular functions. By controlling intracellular
vesicular pH and local extracellular pH, V-ATPases are
crucial for lysosomal function, synaptic transmission, bone
resorption, inner ear endolymph pH regulation, and systemic
acid–base homeostasis by participating in renal acid
excretion.1,2
The V-ATPase consists of two multisubunit domains
termed V0 and V1. The 640 kDa V1 domain is composed of
subunits A–H in a reported A3B3C1D1E1F1G2H1 stoichiome-
try, and the 260 kDa V0 domain is composed of five subunits
in a possible complex of a1d1c
00
1(c, c
0)6.
3 The existence of
the c0 subunit in organisms other than yeast is currently
uncertain. Most subunits have several isoforms that are
expressed in tissue-specific patterns. In mammals, there are
two different B subunit isoforms in the V1 domain. B2 is
ubiquitous, whereas B1 is restricted to specialized epithelia of
the inner ear, epididymis, and the distal renal tubule.3–6
Missense, nonsense, frameshift, and splice junction muta-
tions in the B1 subunit gene ATP6V1B1 have been shown to
be responsible for autosomal-recessive distal tubular acidosis
with sensorineural deafness.7,8 Distal tubular acidosis is
caused by failure of the intercalated cells in distal acidifica-
tion, leading to metabolic acidosis, growth retardation,
osteopenia, nephrolithiasis, nephrocalcinosis, and progressive
renal failure. In addition, impaired cochlear endolymph pH
maintenance leads to sensorineural deafness.
Although the genotype–phenotype association has been
described, the mechanisms by which these mutations cause
human disease are not known. Recently, Yang et al.9
postulated that mutant B1 subunits may have a dominant-
negative effect on native wild-type B1 subunits when
transfected into mammalian cells.
Owing to the absence of a clean mammalian expression
system devoid of native V-ATPase subunits for the functional
analysis of human V-ATPase mutations, we established a
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functional complementation assay in yeast to investigate the
functional consequences of human B1 subunit mutations.
The yeast assay was used in conjunction with more
conventional mammalian cell assays of V-ATPase assembly,
namely immunoprecipitation and immunocytochemistry.
We report a novel, unique near C-terminal frameshift
mutation in the ATP6V1B1 gene and show lack of B1–E
subunit interaction, failed V-ATPase assembly, and conse-
quent loss of function as disease-causing mechanisms.
Through analysis of all known missense mutations in the
ATP6V1B1 gene, we propose lack of V-ATPase assembly as a
common underlying mechanism of B1 subunit-associated
human disease. Additionally, the extension of our analysis to
common ATP6V1B1 single-nucleotide polymorphisms
(SNPs) and the discovery of a common SNP (p.Glu161Lys)
leading to diminished V-ATPase activity despite intact
assembly further extend the spectrum of V-ATPase-associated
disease.
RESULTS
Mutation of ATP6V1B1
Genomic DNA sequence analysis in a large, previously
phenotypically characterized Mexican family with severe
distal renal tubular acidosis and deafness10 revealed a
novel frameshift mutation in exon 14 of the ATP6V1B1 gene
resulting from a GT duplication at position 1401
(c.1401_1402dupGT). Homozygosity of this mutation segre-
gates completely with classical distal renal tubular acidosis in
the kindred. In contrast to all the reported ATP6V1B1
mutations that are located in the first two-thirds of the
B1 subunit, the novel mutation results in a truncation
near the C-terminus and insertion of 19 amino acids
(p.Phe468fsX487) (Figure 1).
Identification of V1 domain assembly disruption as the
molecular mechanism for the novel disease-causing mutation
As the V-ATPase undergoes complex assembly and proces-
sing,2,11 we examined V1 domain assembly as a potential
molecular basis of dysfunction. We expressed epitope-tagged
human wild-type and disease-associated p.Phe468fsX487
(mutant) B1 subunits in distal tubule-like Madin–Darby
canine kidney (MDCK) cells. Wild-type but not mutant B1
subunits, co-immunoprecipitated with the endogenous V1
domain E subunit in MDCK cells, demonstrating assembly of
the wild-type but not the mutant B1 subunit into the V1
domain (Figure 2a). Identical results were obtained when the
constructs were expressed in a different host cell line (human
embryonic kidney cell line (HEK293)) or when the epito-
pe-tag was relocated (N-terminal FLAG versus C-terminal
anti-hemagglutinin (HA)) (Figure 2a), so the results are
independent of host or tag locale. With the exception of a
class I postsynaptic density 95/discs large/zonula occludens-1
(PDZ)-binding motif14,15 at the C-terminus of the B1
subunit, little is known about the function of the last B30
amino acids of mammalian V-ATPase B subunits.16,17 Two
studies employing cysteine cross-linking of Saccharomyces
cerevisiae V-ATPase V1 domain subunits have identified N-
and C-terminal residues (Glu 106/Asp 199 and Glu 494/Thr
501, respectively) to be important for the interaction with the
E subunit.18 These residues are predicted to reside on the
outer surface of V-ATPase B subunit (Figure 3), near both the
top and the bottom of the V1 domain.
18 Glu 494 and Thr 501
of S. cerevisiae V-ATPase B subunit, however, are in areas
that lack homology to mammalian V-ATPase B subunits
(Figure 1). As the mutation abolishes the PDZ-binding motif
in the B1 subunit, we tested if deletion of this region could
account for the defective V-ATPase assembly, possibly via
disruption of PDZ interaction. As shown in Figure 2a,
disruption of the PDZ-binding motif (DTAL) by truncation
of three amino acids (-TAL) completely eliminated interac-
tion of the B1 subunit with the PDZ protein NHERF-1, but
the ability to integrate into a V1 domain remains completely
intact. Thus, truncation of the PDZ domain is insufficient to
disrupt V1 assembly.
The disruption of V1 assembly was further demonstrated
by analysis of a nondetergent supernatant of transiently
transfected cells, so there is no possibility of release of V1 or
any of its subunits from lipid bilayer (Figure 2b). This
supernatant represents V1 subunits in the cytosol before their
insertion into lipid membrane. In both HEK293 and MDCK
cells, the mutant B1 subunit in the cytosol (preinsertion into
membrane) failed to co-precipitate with subunits E, D, or A.
Premembrane insertion V1 assembly was intact in wild-type
and a previously described polymorphic variant of B1
(p.Glu161Lys) (Figure 2b).
We next localized wild-type or mutant B1 subunits by
immunocytochemistry. MDCK cells overexpressing wild-type
or mutant B1 subunits were treated with cycloheximide
(40 mg ml1) for 8 h to chase expressed tagged proteins to
their final location (Figure 2b). Under laser confocal
microscopy, wild-type B1 subunit demonstrated a character-
istic intracellular ‘vesicular-appearing’ pattern, suggesting
incorporation into the V-ATPase into intracellular membra-
nous compartments, compatible with our biochemical
findings. The identity of these compartments are not known
at present. In contrast, the mutant B1 subunit showed a
diffuse cytoplasmic and interestingly nuclear staining.
Functional assessment of the novel B1 subunit mutation in
yeast
Because of the omnipresence of V-ATPase B subunits in
mammalian cells, we deployed a S. cerevisiae strain devoid of
the endogenous yeast B subunit (Vma2p) for definitive
functional assessment of wild-type and mutant human B1
subunits without contamination from native B subunits. The
Vma2p-null strain grows at acidic pH but fails to grow at
neutral or alkaline pH. Growth at neutral or alkaline pH can
be rescued by expression of Vma2p.16,17,20 Figure 2c shows
transformed yeast in a dilution series on a pH-7.5 yeast
extract peptone dextrose (YEPD) agar plate after growth for 4
days at 251C.21 Complementation of the deleted endogenous
yeast Vma2p subunit (growth at pH 7.5) was observed in
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yeast-expressing wild-type but not mutant human B1
subunits. Identical results were obtained for untagged
expression constructs and chimeric constructs where the
C-terminus of the yeast Vma2p subunit was replaced with a
human wild-type or mutant B1 subunit C-terminus (data not
shown). In addition, no dominant-negative effect was
observed when wild-type and mutant human B1 subunits
were co-expressed (data not shown), which is consistent with
the lack of an obvious clinical phenotype in the heterozygous
individuals.
Growth at pH 5.5 was the same for all constructs tested
and no toxic effects of individual constructs were observed
(data not shown). Growth of transformed yeast-expressing
wild-type human B1 subunit requires functional assembly of
V0 and V1 domains. As V1 domain assembly is a stepwise
process,11 biochemical evidence of B1 subunit interactions
with other V1 domain subunits does not guarantee full V1
domain assembly. The yeast data, however, demonstrate that
the human wild-type B1 subunit constructs assemble into
complete and functional V1 domains.
The B1 subunit C-terminus is critical for interaction with the E
subunit
To further delineate the importance of the B1 subunit
C-terminus in V-ATPase assembly, we generated serial
C-terminus truncations (Figure 3) and analyzed both V1
domain assembly in HEK293 cells and functional comple-
mentation in yeast. At equal expression levels in HEK293 cells
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Figure 1 | A novel ATP6V1B1 frameshift mutation. Wild-type and mutant (c.1401_1402dupGT) nucleotide sequences of exon 14 are
shown in the upper panel. Alignment of C-terminal amino-acid sequences of human wild-type (WT) and mutant (p.Phe468fsX487; M) B1,
human B2, and S. cerevisiae Vma2p subunits. The frameshift-induced amino-acid change is shown in red, and the B1 subunit C-terminal
PDZ-binding motif (DTAL) is shown in blue (lower panel).
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Figure 2 | Detailed analysis of the p.Phe468fsX487 mutation. (a) Co-immunoprecipitation in MDCK cells transiently co-expressing
C-terminal HA-tagged NHERF-1 and N-terminal FLAG-tagged B1 subunit constructs (WT, wild-type, M, mutant, -TAL, 3 amino-acid
truncation, left panel). Immunoprecipitation (IP) was performed with an a-FLAG antibody; immunoblotting (IB) with antibodies is shown.
a-E is against the native E subunit.12 In the right panel, HEK293 cells were transfected with N-terminal FLAG- or C-terminal HA-tagged B1
subunit. Immunoprecipitation was performed with either a-FLAG or a-HA antibodies and immunoblotting with depicted antibodies.
(b) HEK293 cells and MDCK cells were transiently transfected with wild-type (WT), mutant (M), and a common polymorphic variant
p.Glu161Lys (E161K) of B1. Cells were broken with Polytron in the total absence of detergent and the supernatants were retrieved after
50 000 g centrifugation and immunoblotted with the indicated antisera. (c) MDCK cells transiently expressing wild-type (WT) or mutant (M)
N-terminal FLAG-tagged B1 subunits after 8 h of cycloheximide chase (40 mg ml1). Cells were labeled with a primary a-FLAG antibody
and a secondary antibody conjugated to Texas Red (red) and counter-stained with DAPI (blue). (d) S. cerevisiae Vma2p-null strain,
expressing C-terminal HA-tagged constructs in a p426TEF expression vector,13 grown on pH-7.5 YEPD plates for 5 days. A total of 5 104
cells were plated with serial 10-fold dilutions (left to right). The right panel shows the relative levels of expression of the constructs by
immunoblot detected with an a-HA antibody.
Kidney International (2008) 73, 1151–1158 1153
DG Fuster et al.: Novel and known ATP6V1B1 mutants dysfunction o r i g i n a l a r t i c l e
(Figure 4a, upper panel), truncations of the B1 subunit D510
(-TAL), D501, and D490 still allow V1 domain assembly
(Figure 4a, lower panel). Whereas the interaction with the
endogenous E subunit is weak in truncation D490 compared
with wild type, the D501 truncation seems to enhance the
interaction. When expressed in MDCK cells, wild-type B1
displayed a vesicular pattern and p.Phe468fsX487 mutant
shows the abnormality as described earlier (Figure 4b).
Although D510, D501, and to a certain extent D490 still
exhibit wild-type morphology, further truncations led to a
complete loss of the pattern seen in wild-type B1.
When tested for functional complementation in the
Vma2p-null strain, D510 and D501 support growth at
alkaline pH comparable with the wild-type B1 subunit,
whereas growth of D490 is considerably weaker (Figure 4c,
lower panel), a finding that is in concordance with the weaker
V1 domain assembly in HEK293 cells. Expression levels of
truncated B1 subunits in yeast were equal for all constructs
(Figure 4c, upper panel). Thus, truncations beyond amino
acid 490 of the B1 subunit disrupt V1 domain assembly
and V-ATPase function. Figure 1 shows the high level of
conservation of amino acids preceding truncation D490.
These results demonstrate the importance of the B1 subunit
C-terminus in V-ATPase assembly. Structural homology
modeling with the X-ray crystal structure of bovine F-ATPase
a subunit predicts an a-helix between amino-acid residues
490 and 505 of the B1 subunit (Figure 3). Our results support
Gln505
Glu501
Arg479
Pro490
Phe468
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Arg124Trp
Thr275Pro
Gly78Arg
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Lly316Glu
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Pro346Arg
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Figure 3 | Structural model of human V-ATPase B1 subunit.
The model was constructed with the Swiss-PdB viewer using the
X-ray crystal structure of bovine F-ATPase a subunit as template
and coordinates obtained from the Protein Data Bank (accession
number 1bmfE).19 The structure is oriented such that the region
farthest from the membrane is at the top, the external surface of
the V1 domain is shown on the right, whereas the region of the B1
subunit oriented toward the interior of the V1 domain is shown
in the left. Point mutations used in this study are shown in red
and C-terminus truncations are shown in black. C- and N-terminal
amino-acid residues are missing because of a lack of homology to
the bovine F-ATPase a subunit.
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Figure 4 | Analysis of C-terminus truncations of the human
V-ATPase B1 subunit. (a) HEK293 cells expressing N-terminal
FLAG-tagged B1 subunit truncations (upper panel). A total of
40mg of lysate protein were loaded and immunoblotting (IB) was
performed using an a-FLAG antibody. The lower panel shows
co-immunoprecipitation of endogenous E subunit after
immunoprecipitation of B1 subunit truncations with an a-FLAG
antibody in HEK293 cells. (b) MDCK cells were transiently
transfected with N-terminal FLAG-tagged wild-type (WT), mutant
(M), and various C-terminal truncations of B1. After 8 h of
cycloheximide chase (40 mg ml1), cells were labeled with a
primary a-FLAG antibody and a secondary antibody conjugated
to Texas Red (red) and counter-stained with DAPI (blue). (c) S.
cerevisiae Vma2p-null strain expressing C-terminal HA-tagged B1
subunit truncation constructs. A total of 5 104 cells were plated
with serial 10-fold dilutions (top to bottom) on a pH-7.5 YEPD
plate, and growth was assessed after 5 days (lower panel). The
upper panel shows expression of the truncation constructs in
yeast by immunoblot detected with an a-HA antibody. Equal
amounts of yeast lysates from 1 o.d. unit were loaded.
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a pivotal role of this very C-terminal a-helix in the
association between E and B1 subunit in the V1 domain.
This hypothesis is supported by the fact that not the length
per se but the specific amino-acid sequence of the C-terminus
is important for interaction with the E subunit, as a C-
terminal HA-tagged mutant B1 subunit with a total of 495
amino acids also fails to assemble (Figure 1).
Molecular mechanism for disease-causing B1 subunit
mutations
Having identified lack of V1 domain assembly and con-
secutive loss of function as a mechanism of a human
V-ATPase-associated disease, the question arises if assembly
failure is a common underlying mechanism of ATP6V1B1
mutations. We therefore analyzed all described ATP6V1B1
missense mutations: c.232G4A (p.Gly78Arg); c.242T4C
(p.Leu81Pro); c.368G4T (p.Gly123Val); c.370C4T (p.Arg
124Trp); c.469C4T (p.Arg157Cys); c.521T4G (p.Met174
Arg); c.823A4C (p.Thr275Pro); c.947G4A (p.Gly316Glu);
c.1037C4G (p.Pro346Arg) and c.1090G4A (p.Gly364
Ser) and two frequent SNPs c.89C4T (p.Thr30Ile) and
c.481G4A (p.Glu161Lys) that have previously been de-
scribed to be in Hardy–Weinberg equilibrium in control
populations and believed to have no functional impact on
pump function.7,8,22 Figure 3 shows the location of the
mutations and SNPs in the putative B1 subunit structure.
There are additionally reported nonsense and frameshift
mutations leading to early stop codons in the transcript,
likely to result in severely truncated B1 subunits and were
thus not included in our analysis. As shown in the lower
panel of Figure 5a, all missense base changes fail to interact
with the E subunit except p.Thr30Ile, p.Glu161Lys, and
p.Gly316Glu, which all retain efficient V1 domain assembly.
Mutant and wild-type B1 subunit constructs were expressed
at equal levels in HEK293 cells (Figure 5b).
All reported missense mutations except one (p.Thr30Ile)
fail to support growth of transformed yeast at alkaline pH,
further validating our functional assay in yeast. The point
mutant p.Thr30Ile was similar to wild-type B1 subunit,
suggesting that this is a fully functional polymorphic allele. In
contrast, p.Glu161Lys exhibits poor growth at alkaline pH,
suggesting that this is not a silent SNP but possibly a
dysfunctional missense mutation. In contrast to Thr 30, Glu
161 is conserved in animals, fungi, and plants. The few
exceptions include Glu–to-Gln transitions in Neurospora
crassa and Dictostelium discoideum and Glu-to-Lys transitions
in Apis mellifera, Plasmodium falciparum, Blastocystis hominis,
and Tetrahymena thermophila.
DISCUSSION
In humans, mutations in the V-ATPase subunit genes B1
(ATP6V1B1), a3 (ATP6V0A3), and a4 (ATP6V0A4) are
associated with distal renal tubular acidosis with sensor-
ineural deafness (ATP6V1B1), distal renal tubular acidosis
with variable sensorineural deafness (ATP6V0A4), or malig-
nant infantile osteopetrosis (ATP6V0A3).7,8,23 A murine
deletion model of the B1 subunit highlights the requirement
of the B1 subunit in sustaining maximal urinary acidifica-
tion.1 Difficulties in studying human V-ATPase subunit
mutations lie in the complexity of the multisubunit V-
ATPase, the lack of clean cell culture models, and in the case
of B1 subunit mutations, the ubiquitous presence of B
subunits in mammalian cells. The yeast S. cerevisiae contains
only one endogenous B subunit. Diploid null strains are
readily available and have been thoroughly character-
ized.7,16,20 S. cerevisiae strains deficient in V-ATPase subunits
are lethal secondary to a failure to lower the pH in the
vacuolar system, and mutants only survive if a low external
pH allows for vacuolar acidification presumably by fluid-
phase endocytosis.7 Although mouse d and E subunits of the
V-ATPase have been successfully used for functional com-
plementation in yeast strains deficient in the cognate
V-ATPase subunits, successful complementation with a
mammalian V-ATPase B1 subunit has not been described.24,25
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Figure 5 | Analysis of ATP6V1B1 missense mutations.
(a) HEK293 cells expressing N-terminal FLAG-tagged B1 subunit
point mutations (upper panel). A total of 40mg of lysate protein
were loaded and immunoblotting (IB) was performed using an
a-FLAG antibody. The lower panel shows co-immunoprecipitation
of endogenous E subunit after immunoprecipitation of B1 subunit
truncations with an a-FLAG antibody in HEK239 cells. (b) S.
cerevisiae Vma2p-null strain expressing C-terminal HA-tagged B1
subunit point mutation constructs. A total of 5 104 cells were
plated with serial 10-fold dilutions (top to bottom) on a pH-7.5
YEPD plate and growth was assessed after 5 days (lower panel).
The upper panel shows expression of the point mutation
constructs in yeast by immunoblot detected with an a-HA
antibody. Equal amounts of yeast lysates from 1 o.d. unit were
loaded.
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We demonstrate that the yeast S. cerevisiae is an ideal
heterologous expression system for the functional analysis of
human B1. The novel B1 subunit frameshift mutation
(p.Phe468fsX487) illustrates the importance of the B1
subunit C-terminus in V-ATPase assembly. Furthermore,
our analysis of all known B1 subunit missense mutations
indicates lack of V1 domain assembly as a rather common
molecular mechanism of V-ATPase dysfunction in B1 subunit
mutations. Further studies will have to be performed to
address the exact mechanisms leading to disrupted V-ATPase
assembly. In the case of p.Glu161Lys or p.Gly316Glu
mutation, the reasons for loss of function despite intact
assembly can be due to defective ATP binding and hydrolysis
or uncoupling of ATP hydrolysis to Hþ translocation.
Yang et al.9 demonstrated disrupted V-ATPase assembly in
seven known ATP6V1B1 missense mutations using mamma-
lian cells. Based on the fact that overexpressed mutant B1
subunits can lower Naþ -independent cell pH recovery after
acid load in a rat inner medullary collecting duct cell line,
they proposed a dominant-negative mechanism of the
transfected mutant B1 subunits over the native wild-type
B1 subunit. In contrast, we did not find a dominant-negative
effect of the novel frameshift mutation in our yeast assay. The
discrepancy can be due to different expression system and
different assays for Hþ -pump function. Dominant-negative
effects have also been observed for the a3 and a4 subunits in a
yeast complementation system.26 The literature shows that
heterozygously affected individuals of ATP6V1B1 missense
mutations do not have a lower plasma bicarbonate
concentration or higher urine pH but more provocative
studies are not available. Thus, the notion of a dominant-
negative effect raised by Yang et al.9 is highly intriguing and
requires further investigation. Another interesting point is
that the B2 isoform is expressed in mammalian cells and B2
has been shown to complement partially for loss of B1 in B1-
null mice.27–30
For the p.Gly316Glu mutant B1 subunit, Yang et al.9
showed absence of interaction with the native E subunit. In
our hands, the p.Gly316Glu mutant B1 subunit repeatedly
co-immunoprecipitated with the native E subunit (Figure 5a)
as well as subunits A and D (not shown), suggesting full V1
assembly. The reasons for the divergent findings are currently
unclear, but may lie in the different antibodies (a-green
fluorescent protein versus a-FLAG) or epitope tagging (N-
terminal GFP versus N-terminal FLAG) employed and
require further testing.
Our finding of impaired function of a common
ATP6V1B1 SNP (p.Glu161Lys) has important clinical
implications, as it further extends the spectrum of
V-ATPase-associated disease. This SNP was found to be in
Hardy–Weinberg equilibrium in Turkish and Saudi Arabian
control subjects with an estimated allele frequency of 10%.8
We currently do not have adequate phenotypic information
on heterozygotes versus homozygotes with this variant allele.
The frequency of this SNP will have to be determined in
other populations and the phenotype defined by metabolic
studies. A true allele frequency of 10% predicts homozygosity
of 1:100, assuming strict adherence to simple Mendelian
inheritance. It is conceivable that homozygously affected
individuals may have impaired renal tubular acid secretion,
especially under physiological stress situations. Partial
impairment in distal tubular acid secretion is known as
incomplete or partial distal renal tubular acidosis and has
been associated with osteoporosis and nephrolithiasis.31,32
These patients have normal blood pH and bicarbonate levels
but fail to maximally acidify their urines when challenged.
Systematic screening of high-risk populations may identify
additional polymorphisms with reduced V-ATPase activity.
MATERIALS AND METHODS
Materials
Chemicals were obtained from Sigma-Aldrich (St Louis, MD, USA)
except the following: Lipofectamine 2000 and restriction enzymes
(Invitrogen, Carlsbad, CA, USA); PCR primers (Integrated DNA
technologies, Coralville, IA, USA); Easy-A PCR mix (Stratagene, La
Jolla, CA, USA); cell culture media and geneticin (Gibco BRL); fetal
bovine serum (Atlanta Biologicals, Norcross, CA, USA); penicillin
and streptomycin (Whittaker MA Bioproducts, Abbott Park, IL,
USA); T4 DNA ligase and mini-EDTA-free protease inhibitor
cocktail tablets (Roche); protein-G-agarose (Calbiochem, San Diego,
CA, USA); rabbit polyclonal anti-FLAG, mouse monoclonal anti-
FLAG, and HA antibodies (Sigma); horseradish peroxidase-con-
jugated sheep anti-mouse and donkey anti-rabbit IgG antibodies
and enhanced chemiluminescence detection kit (Amersham, Beverly,
MA, USA); polyvinylidene difluoride membranes (Immobilon,
Billerica, MA, USA); Texas Red-conjugated goat anti-rabbit IgG
antibody (Molecular Probes, Eugene, OR, USA); MDCK and HEK293
cells and S. cerevisiae YBR127C (Vma2p)-null strain (ATCC, Rockville,
MD, USA); full-length Vma2p cDNA (Open Biosystems, Woburn,
MA, USA); D-glucose (Fluka, St Louis, MD, USA); yeast nitrogen base
(BD Biosciences, San Jose, CA, USA); -Ura DO supplement (Clontech,
Palo Alto, CA, USA). Rabbit polyclonal antibody detecting V-ATPase E
subunit was described earlier by Peng et al.33
DNA analysis
The large Mexican family was characterized phenotypically.10 All
homozygotes were affected but heterozygotes did not display
clinically obvious metabolic acidosis or deafness. All participants
gave informed consent to a protocol approved by the Institutional
Review Board at UT Southwestern Medical Center. Genomic DNA
was prepared from peripheral blood lymphocytes and ATP6V1B1
exons and exon–intron boundaries were amplified by PCR using
fluorescently end-labeled primers on a PE Applied Biosystems
model 377 automated DNA sequencer. The primers used have been
described by Karet et al.7,8 Samples were analyzed by 4%
polyacrylamide gels and data analysis was performed using
GENOTYPER software.
Mammalian and yeast expression constructs
Full-length human B1 subunit cDNA was amplified by PCR from
a human kidney cDNA library (Clontech). Point mutations were
introduced by PCR-based mutagenesis. cDNA fragments were
inserted in-frame into C-terminal single HA-tagged PMH
(Roche) or N-terminal triple FLAG-tagged p3xFLAG-CMV-10
(Sigma-Aldrich) vectors for mammalian expression constructs
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and into the p426TEF vector for expression in yeast.13 All yeast
constructs contain a yeast translation initiation consensus
sequence (AAAA) and two in-frame stop codons. C-terminal
single HA-tags were introduced by PCR. All constructs were
verified by sequencing.
Yeast transformation and growth selection
Expression constructs were transformed into S. cerevisiae (genotype
MATa/MATalpha his3D1/his3D1 leu2D0/leu2D0 lys2D0/þ
met15D0/þ ura3D0/ura3D0 DVMA2/DVMA2) and grown at
251C in YEPD medium (10 g l1 yeast extract, 20 g l1 peptone,
20 g l1 D-glucose, 100 mg l1 adenine hemisulfate, 50 mM metha-
nesulfonic acid, pH 5.5, or 50 mM 3-(N-morpholino)propanesulfo-
nic acid, pH 7.5) or the synthetic minimal uracil (SD-Ura) dropout
medium (-Ura DO supplement 0.77 g l1, yeast nitrogen base 6.7,
20 g l1 D-glucose, 100 mg l1 adenine hemisulfate, 50 mM metha-
nesulfonic acid, pH 5.5). All yeast media contained 200 mg ml1
geneticin. Transformation of yeast was performed as described by
Gietz et al.21 Single colonies were isolated on pH-5.5 SD-Ura plates
and growth of transformants was assayed on YEPD plates buffered
to pH 5.5 or 7.5.
For immunoblot, 10 o.d. units of yeast grown in SD-Ura
medium were washed once with 1 mM EDTA/H2O and lysed in 2 M
NaOH for 10 min on ice. Proteins were isolated by trichloroacetic
acid/acetone precipitation and resuspended in SDS sample buffer
(25 mM Tris-Cl, pH 6.8, 9 M urea, 1 mM EDTA, 1% (w/v) SDS, 0.7 M
b-mercaptoethanol, 10% (v/v) glycerol). After incubation (371C,
15 min), equal portions of the lysates were separated by SDS-PAGE,
transferred to polyvinylidene difluoride membranes, and analyzed
by immunoblotting.
Cell culture and transfection
MDCK and HEK293 cells were cultured at 371C in 95% air/5% CO2
in high-glucose (450 mg dl1) DMEM supplemented with 10% (v/v)
fetal bovine serum, penicillin (100 U ml1) and streptomycin
(100 mg ml1). Transient transfections were performed with Lipo-
fectamine 2000 and cells were used 36–48 h after transfection for
further experiments.
Immunoprecipitation and immunoblotting
For immunoprecipitation, cells were grown in six-well plates and
lysed in a buffer containing 0.5% (v/v) Triton X-100 in TBS with
fresh protease inhibitors. The lysates were cleared by centrifugation
(14 000 g 30 min), precipitating antibodies (1:200 dilution) and
prewashed protein-G-agarose (30 ml of 50% slurry) were added, and
lysates were rotated for 4 h at 41C. After washing three times with
lysis buffer, proteins were eluted from the beads with 2.5 loading
buffer (2.5 mM Tris-Cl, pH 6.8, 2.5% SDS, 2.5% b-mercaptoethanol,
25% glycerol), heated (2 min, 951C), separated by SDS-PAGE and
transferred to polyvinylidene difluoride membranes. Primary
antibodies were used at a 1:1000 dilution, and secondary horse-
radish peroxidase-conjugated sheep anti-mouse and donkey anti-
rabbit IgG antibodies were used at 1:20 000 dilutions, and signals
were detected using enhanced chemiluminescence.
Immunocytochemistry
Forty hours after transfection, MDCK cells were treated with
cylcoheximide (40 mg ml1) for 8 h. Cells were fixed with 4%
paraformaldehyde, permeabilized with 0.1% Triton X-100, and
blocked by 1.5% BSA/10% goat serum for 1 h. Specimens were
incubated with rabbit anti-FLAG polyclonal antibody (1:200
dilution, 12 h, 41C), followed by Texas Red-conjugated goat anti-
rabbit IgG antibody (1:500 dilution; 2 h). Confocal fluorescence
images were acquired through a Zeiss  100 objective lens using a
Zeiss LSM-510 laser-scanning confocal microscope. Fluorescence of
Texas Red and DAPI were detected using excitation laser
wavelengths (in nm) of 568 and 350, respectively.
Equipment and settings
Immunoblots were scanned with ScanMaker X6EL (Microtek,
Cerritos, CA, USA) scanner and Adobe Photoshop (version 7.0)
software (resolution of 600 dpi) and otherwise default settings.
Blot images were cropped, combined in CorelDraw (version 11),
and then converted to TIFF files without image processing. Images
of yeast plates were acquired using a Canon S2 IS digital camera at
5-megapixel resolution as low-compression JPEG files, and with-
out further processing, images were cropped and converted to
grayscale TIFF files. Individual experiments were repeated at least
three times.
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